104 related articles for article (PubMed ID: 38872398)
1. Internal validation of Automated Visual Evaluation (AVE) on smartphone images for cervical cancer screening in a prospective study in Zambia.
Hu L; Mwanahamuntu MH; Sahasrabuddhe VV; Barrett C; Horning MP; Shah I; Laverriere Z; Banik D; Ji Y; Shibemba AL; Chisele S; Munalula MK; Kaunga F; Musonda F; Malyangu E; Hariharan KM; Parham GP
Cancer Med; 2024 Jun; 13(11):e7355. PubMed ID: 38872398
[TBL] [Abstract][Full Text] [Related]
2. Internal Validation of Automated Visual Evaluation (AVE) on Smartphone Images for Cervical Cancer Screening in a Prospective Study in Zambia.
Hu L; Mwanahamuntu MH; Sahasrabuddhe VV; Barrett C; Horning MP; Shah I; Laverriere Z; Banik D; Ji Y; Shibemba AL; Chisele S; Munalula MK; Kaunga F; Musonda F; Malyangu E; Hariharan KM; Parham GP
medRxiv; 2024 Feb; ():. PubMed ID: 37560093
[TBL] [Abstract][Full Text] [Related]
3. Study protocol for a two-site clinical trial to validate a smartphone-based artificial intelligence classifier identifying cervical precancer and cancer in HPV-positive women in Cameroon.
Baleydier I; Vassilakos P; Viñals R; Wisniak A; Kenfack B; Tsuala Fouogue J; Enownchong Enow Orock G; Lemoupa Makajio S; Foguem Tincho E; Undurraga M; Cattin M; Makohliso S; Schönenberger K; Gervaix A; Thiran JP; Petignat P
PLoS One; 2021; 16(12):e0260776. PubMed ID: 34914727
[TBL] [Abstract][Full Text] [Related]
4. [A study of cervical cancer screening algorithms].
Zhao FH; Zhang WH; Pan QJ; Zhang X; Chen W; Liu B; Ma JF; Hu SY; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):420-4. PubMed ID: 20819481
[TBL] [Abstract][Full Text] [Related]
5. Smartphone Use for Cervical Cancer Screening in Low-Resource Countries: A Pilot Study Conducted in Madagascar.
Catarino R; Vassilakos P; Scaringella S; Undurraga-Malinverno M; Meyer-Hamme U; Ricard-Gauthier D; Matute JC; Petignat P
PLoS One; 2015; 10(7):e0134309. PubMed ID: 26222772
[TBL] [Abstract][Full Text] [Related]
6. A demonstration of automated visual evaluation of cervical images taken with a smartphone camera.
Xue Z; Novetsky AP; Einstein MH; Marcus JZ; Befano B; Guo P; Demarco M; Wentzensen N; Long LR; Schiffman M; Antani S
Int J Cancer; 2020 Nov; 147(9):2416-2423. PubMed ID: 32356305
[TBL] [Abstract][Full Text] [Related]
7. Triage of HPV positivity in a high HIV prevalence setting: A prospective cohort study comparing visual triage methods and HPV genotype restriction in Botswana.
Luckett R; Ramogola-Masire D; Gompers A; Moraka N; Moyo S; Sedabadi L; Tawe L; Kashamba T; Gaborone K; Mathoma A; Noubary F; Kula M; Grover S; Dreyer G; Botha MH; Makhema J; Shapiro R; Hacker MR
Int J Gynaecol Obstet; 2024 May; 165(2):507-518. PubMed ID: 37950533
[TBL] [Abstract][Full Text] [Related]
8. Cytology versus HPV testing for cervical cancer screening in the general population.
Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
[TBL] [Abstract][Full Text] [Related]
9. Deep learning-based image evaluation for cervical precancer screening with a smartphone targeting low resource settings - Engineering approach.
Hu L; Horning MP; Banik D; Ajenifuja OK; Adepiti CA; Yeates K; Mtema Z; Wilson B; Mehanian C
Annu Int Conf IEEE Eng Med Biol Soc; 2020 Jul; 2020():1944-1949. PubMed ID: 33018383
[TBL] [Abstract][Full Text] [Related]
10. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
[TBL] [Abstract][Full Text] [Related]
11. Validation in Zambia of a cervical screening strategy including HPV genotyping and artificial intelligence (AI)-based automated visual evaluation.
Parham GP; Egemen D; Befano B; Mwanahamuntu MH; Rodriguez AC; Antani S; Chisele S; Munalula MK; Kaunga F; Musonda F; Malyangu E; Shibemba AL; de Sanjose S; Schiffman M; Sahasrabuddhe VV
Infect Agent Cancer; 2023 Oct; 18(1):61. PubMed ID: 37845724
[TBL] [Abstract][Full Text] [Related]
12. Performance and Diagnostic Accuracy of a Urine-Based Human Papillomavirus Assay in a Referral Population.
Cuzick J; Cadman L; Ahmad AS; Ho L; Terry G; Kleeman M; Lyons D; Austin J; Stoler MH; Vibat CRT; Dockter J; Robbins D; Billings PR; Erlander MG
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1053-1059. PubMed ID: 28223432
[No Abstract] [Full Text] [Related]
13. Performance of alternative strategies for primary cervical cancer screening in sub-Saharan Africa: systematic review and meta-analysis of diagnostic test accuracy studies.
Fokom-Domgue J; Combescure C; Fokom-Defo V; Tebeu PM; Vassilakos P; Kengne AP; Petignat P
BMJ; 2015 Jul; 351():h3084. PubMed ID: 26142020
[TBL] [Abstract][Full Text] [Related]
14. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
15. Persistence and clearance of high-risk human papillomavirus and cervical dysplasia at 1 year in women living with human immunodeficiency virus: a prospective cohort study.
Luckett R; Painter H; Hacker MR; Simon B; Seiphetlheng A; Erlinger A; Eakin C; Moyo S; Kyokunda LT; Esselen K; Feldman S; Morroni C; Ramogola-Masire D
BJOG; 2021 Nov; 128(12):1986-1996. PubMed ID: 34008294
[TBL] [Abstract][Full Text] [Related]
16. Deep learning based cervical screening by the cross-modal integration of colposcopy, cytology, and HPV test.
Fu L; Xia W; Shi W; Cao GX; Ruan YT; Zhao XY; Liu M; Niu SM; Li F; Gao X
Int J Med Inform; 2022 Mar; 159():104675. PubMed ID: 34979436
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus-based cervical precancer screening with visual inspection with acetic acid triage to achieve same-day treatments among women living with human immunodeficiency virus infection: test-of-concept study in Ibadan, Nigeria.
Awolude OA; Oyerinde SO; Ayeni AO; Adewole IF
Pan Afr Med J; 2021; 40():48. PubMed ID: 34795828
[TBL] [Abstract][Full Text] [Related]
18. Screening of cervical neoplasia in HIV-infected women in India.
Joshi S; Sankaranarayanan R; Muwonge R; Kulkarni V; Somanathan T; Divate U
AIDS; 2013 Feb; 27(4):607-15. PubMed ID: 23079814
[TBL] [Abstract][Full Text] [Related]
19. Screening test accuracy to improve detection of precancerous lesions of the cervix in women living with HIV: a study protocol.
Taghavi K; Moono M; Mwanahamuntu M; Basu P; Limacher A; Tembo T; Kapesa H; Hamusonde K; Asangbeh S; Sznitman R; Low N; Manasyan A; Bohlius J
BMJ Open; 2020 Dec; 10(12):e037955. PubMed ID: 33371015
[TBL] [Abstract][Full Text] [Related]
20. PERFORMANCE OF SMARTPHONE-BASED DIGITAL IMAGES FOR CERVICAL CANCER SCREENING IN A LOW-RESOURCE CONTEXT.
Tran PL; Benski C; Viviano M; Petignat P; Combescure C; Jinoro J; Herinianasolo JL; Vassilakos P
Int J Technol Assess Health Care; 2018 Jan; 34(3):337-342. PubMed ID: 29921339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
